Product name:FG-2216
Description:A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
FG-2216
Send Enquiry Online
This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.For more information OR other products. Please contact us by Email, Tel, Fax or Send online enquiry. We will reply you as soon as possible.
1. Email: sales@chemicalspharm.com
2. Tel: +86 592 5365887